MedicarePartD.guide

A non-government resource built from CMS public data

Mounjaro on Horizon Medicare Blue Rx Enhanced (S5993-003)

tirzepatide injection

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 2 per 28 days.

$218.90
Patient pays / month, after deductible
$378.90
Patient pays / month, before the $200.00 deductible
$656.69
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

MOUNJARO 7.5 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,094.49 for a month. Other covered strengths are listed below.

Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
FormTierPatient pays / monthLimits
MOUNJARO 15 mg/.5mL Injection, Solution3$219.19PA · 2 per 28 days
MOUNJARO 12.5 mg/.5mL Injection, Solution3$219.10PA · 2 per 28 days
MOUNJARO 10 mg/.5mL Injection, Solution3$218.91PA · 2 per 28 days
MOUNJARO 7.5 mg/.5mL Injection, Solution3$218.90PA · 2 per 28 days
MOUNJARO 5 mg/.5mL Injection, Solution3$218.93PA · 2 per 28 days
MOUNJARO 2.5 mg/.5mL Injection, Solution3$219.16PA · 2 per 28 days

Other GLP-1s on this plan

Verify with the plan before prescribing or filling. Member services: (800)391-1906. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5993-003